Are you Dr. Chang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2966Fax+1 415-353-2167
Summary
- Dr. Susan Chang, MD is a neurosurgeon in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with UCSF Medical Center and Zuckerberg San Francisco General Hospital and Trauma Center.
Education & Training
- University of British ColumbiaClass of 1985
Certifications & Licensure
- CA State Medical License 1992 - 2026
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas Start of enrollment: 2000 Jun 01
- CCI-779 in Treating Patients With Malignant Glioma Start of enrollment: 2001 Aug 27
- Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma Start of enrollment: 2003 Mar 07
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults.Benjamin M Ellingson, Francesco Sanvito, Timothy F Cloughesy, Raymond Y Huang, Javier E Villanueva-Meyer
AJNR. American Journal of Neuroradiology. 2024-12-09 - Practical and statistical aspects of subgroup analyses in surgical neuro-oncology: A comprehensive review from the PIONEER Consortium.Jasper K W Gerritsen, Philipp Karschnia, Jacob S Young, Martin J van den Bent, Susan M Chang
Neuro-Oncology. 2024-12-07 - Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment re...Calixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, Rohit Gupta, Ramin A Morshed
Neuro-Oncology. 2024-11-19
Press Mentions
- Temozolomide with Radiotherapy Safer, Equally Effective as Nitrosureas for Anaplastic AstrocytomaJune 2nd, 2015
Grant Support
- Intedrated Imagaing And Tissue Biomarkers In Glioblastoma Multiforme Post TherapyNational Cancer Institute2007–2011
- Nabtc Member Intitution Grant (Ucsf Project Leader)National Cancer Institute2004–2008
- CCI-779 In Patients With Malignant GliomaNational Center For Research Resources2004–2005
Professional Memberships
- Member